Strides aims to build on Australia and US
Executive Summary
Unlocking the value of its “large and established portfolio in Australia and the US” by registering and marketing products in other highly regulated markets is a key facet of Strides Pharma Science’s strategy to scale up its business-to-consumer business. ‘Other Regulated Markets’ are expected to be one of the fastest-growing parts of the group.